Get the Stockscreener App
2.30
0.86%
-0.02
Spero Therapeutics Inc stock is traded at $2.30, with a volume of 518.73K.
It is down -0.86% in the last 24 hours and down -20.69% over the past month.
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.
See More
Previous Close:
$2.32
Open:
$2.26
24h Volume:
518.73K
Relative Volume:
0.12
Market Cap:
$128.59M
Revenue:
$76.19M
Net Income/Loss:
$-1.61M
P/E Ratio:
230.00
EPS:
0.01
Net Cash Flow:
$28.98M
1W Performance:
-1.29%
1M Performance:
-20.69%
6M Performance:
+168.50%
1Y Performance:
+65.47%
1-Day Range:
$2.22
$2.325
1-Week Range:
$2.16
$2.435
52-Week Range:
$0.5052
$3.22
Spero Therapeutics Inc Stock (SPRO) Company Profile
Name
Spero Therapeutics Inc
Sector
Industry
Phone
857-242-1600
Address
675 MASSACHUSETTS AVENUE, CAMBRIDGE, MA
Compare SPRO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SPRO
Spero Therapeutics Inc
|
2.30 | 129.71M | 76.19M | -1.61M | 28.98M | 0.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Spero Therapeutics Inc Stock (SPRO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-23-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-01-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-22-21 | Reiterated | H.C. Wainwright | Buy |
| Dec-16-20 | Initiated | Berenberg | Buy |
| Sep-29-20 | Initiated | Evercore ISI | Outperform |
| Nov-05-19 | Reiterated | H.C. Wainwright | Buy |
| Sep-09-19 | Initiated | Janney | Buy |
| Feb-09-18 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-27-17 | Initiated | BofA/Merrill | Neutral |
| Nov-27-17 | Initiated | Oppenheimer | Outperform |
| Nov-27-17 | Initiated | Stifel | Buy |
View All
Spero Therapeutics Inc Stock (SPRO) Latest News
Trend analysis for Spero Therapeutics Inc. this weekSmart Chart Forecasting with AI Algorithms - Newser
Using Python tools to backtest Spero Therapeutics Inc. strategiesMomentum Trading Guide with Safety Limits - Newser
Spero Therapeutics Inc. Breaks Losing Streak — Is the Trend ReversingProfit Target Stock Opportunity Monitor Activated - metal.it
How hedge fund analytics apply to Spero Therapeutics Inc. stock7-Day Equity Return Range Forecast Model - Newser
What momentum shifts mean for Spero Therapeutics Inc.Predictable Income Summary for Long-Term Trades - Newser
Should I hold or sell Spero Therapeutics Inc. stock in 2025Value Investing Picks For Consistent Profits - jammulinksnews.com
What is the risk reward ratio of investing in Spero Therapeutics Inc. stockPre Market Trend Scanner With High Returns - jammulinksnews.com
How Spero Therapeutics Inc. stock performs during market volatilitySmart Trade Forecast Based on Neural Logic - Newser
Spero Therapeutics Inc. Matches Institutional Buying FilterAccurate Buy Point for Momentum Stocks Detected - metal.it
What makes Spero Therapeutics Inc. stock price move sharplyFree Real Time Stock Movement Analysis - Newser
Multi factor analysis applied to Spero Therapeutics Inc.Free Weekly Setup With 3x Return Potential - Newser
Can Spero Therapeutics Inc. Regain Momentum After BreakdownWeekly Top Gainers Forecast Watchlist Released - beatles.ru
Spero Therapeutics Inc. Stock Support and Resistance Levels You Should KnowFree AI Based High Gain Watchlist Scanner - Newser
Will Spero Therapeutics Inc. stock benefit from AI tech trendsAI Triggered Buy Zone Forecast System - Newser
Why is Spero Therapeutics Inc. stock attracting strong analyst attentionSwing Trade Review With Proven Results - jammulinksnews.com
When is Spero Therapeutics Inc. stock expected to show significant growthOutstanding investment returns - jammulinksnews.com
How does Spero Therapeutics Inc. generate profit in a changing economyFree Investment Risk Control - jammulinksnews.com
How volatile is Spero Therapeutics Inc. stock compared to the marketExponentially increasing returns - jammulinksnews.com
Is Spero Therapeutics Inc. stock overvalued or undervaluedExceptional market performance - jammulinksnews.com
What institutional investors are buying Spero Therapeutics Inc. stockMaximize returns with effective portfolio management - jammulinksnews.com
What is the dividend policy of Spero Therapeutics Inc. stockGet real-time alerts on top-performing stocks - jammulinksnews.com
What drives Spero Therapeutics Inc. stock priceTremendous portfolio expansion - PrintWeekIndia
Is Spero Therapeutics Inc. a good long term investmentExceptional market positioning - PrintWeekIndia
What risks could impact Spero Therapeutics Inc. stock performanceConsistently high yield - jammulinksnews.com
What institutions are buying Spero Therapeutics Inc. stock nowBreakneck growth rates - jammulinksnews.com
Why Spero Therapeutics Inc. stock is on top investor watchlistsOutstanding capital appreciation - jammulinksnews.com
What analysts say about Spero Therapeutics Inc. stockSuperior portfolio returns - Autocar Professional
Published on: 2025-07-24 21:52:51 - jammulinksnews.com
Spero Therapeutics Inc. Stock Analysis and ForecastConsistently superior profits - jammulinksnews.com
Spero Therapeutics Inc Stock (SPRO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):